Details

Autor(en) / Beteiligte

• Wade, Spencer D
• Sawicki, Caroline M
• Smiley, Megann K
• Cuddy, Michael A
• Vukas, Steven
• Schwartz, Paul J

Titel

Anesthesia for Dental and Oral Maxillofacial Surgery

Auflage

1st ed

Ort / Verlag

Newark : John Wiley & Sons, Incorporated,

Erscheinungsjahr

2024

Link zum Volltext

• Wiley Online Library - AutoHoldings Books

Beschreibungen/Notizen

• Cover -- Title Page -- Copyright Page -- Dedication Page -- Contents -- Editorial Board -- Acknowledgments and Contributors -- Preface -- Oral/Written Boards -- Dentist Contributions to Anesthesiology -- Glossary of Abbreviations -- Section 1 Statistics I Physics I Equipment -- 1.1 Statistics -- Normal Distribution (Figure 1.1) -- Variables -- Basic Statistical Tests -- Research Methodologies (Figure 1.2) -- 1.2 Anesthetic Monitoring Standards -- Standard I (Figure 1.3) -- Standard II (Figure 1.4) -- 1.3 Pulse Oximetry -- Function -- Clinical Considerations -- 1.4 Electrocardiography -- Function -- Clinical Considerations -- 1.5 Blood Pressure Monitors -- Noninvasive Blood Pressure Cuff -- Arterial Line -- 1.6 Temperature Monitoring -- Function -- Clinical Considerations -- 1.7 Ventilation Monitoring -- Pretracheal/Precordial Stethoscope -- Capnography -- 1.8 Capnograms (Figures 1.9 &amp -- 1.10) -- 1.9 Fluid and Gas Physics -- Laminar Flow -- 1.10 Medical Gas -- Characteristics (Figure 1.13) -- Nitrous Oxide -- Gas Supply Colors (Figure 1.14) -- 1.11 Mapleson Circuit -- Characteristics (Figure 1.15) -- 1.12 Circle System -- Humidifiers -- Carbon Dioxide Absorbent -- 1.13 Anesthesia Machine Safety Features -- 1.14 Vaporizer -- Vapor Pressure (Figures 1.18 &amp -- 1.19) -- Safety Features -- Desflurane Vaporizer -- 1.15 Ventilator -- Common Ventilator Modes -- Components and Safety Features -- 1.16 Infusion Pump -- Components and Safety Features -- References -- Section 2 Anatomy I Physiology -- 2.1 Body Fluids -- Fluid Compartments -- 2.2 Intravenous Fluids -- Fluid Composition -- Crystalloids -- Colloids -- 2.3 Head and Neck Blood Supply (Figures 2.2 &amp -- 2.3) -- 2.4 Sensory Nerves (Figure 2.4) -- 2.5 Cranial Nerves -- CN I (Olfactory) -- CN II (Optic) -- CN III (Oculomotor) -- CN IV (Trochlear) -- CN V (Trigeminal).
• Ophthalmic Branch (V1) -- Maxillary Branch (V2) -- Mandibular Branch (V3) -- CN VI (Abducens) -- CN VII (Facial) -- CN VIII (Vestibulocochlear) -- CN IX (Glossopharyngeal) -- CN X (Vagus) -- CN XI (Spinal Accessory) -- CN XII (Hypoglossal) -- 2.6 Neuromuscular Junction -- Anatomy -- Muscle Contraction -- 2.7 Parasympathetic Nervous System -- Anatomy -- Physiology (Figures 2.10 &amp -- 2.11) -- Receptors -- 2.8 Sympathetic Nervous System -- Anatomy -- Physiology (Figures 2.12 &amp -- 2.13) -- Receptors -- 2.9 Brain -- Anatomy -- Function -- Cerebral Blood Flow (CBF) -- Cerebral Blood Flow Regulation (Figure 2.15) -- Innervation -- Cerebrospinal Fluid -- Anterior Pituitary Hormones -- Posterior Pituitary Hormones -- 2.10 Spinal Cord -- Anatomy -- Function -- Blood Flow -- Innervation -- Endocrine/Exocrine -- 2.11 Cardiac -- Anatomy -- Function -- Cardiac Blood Flow (Figure 2.17) -- Innervation -- Cardiac Output (Figure 2.18) -- Flow-Volume Loop (Figure 2.20) -- Conduction -- Cardiac Action Potentials (Figures 2.21 &amp -- 2.22) -- Endocrine/Exocrine -- 2.12 Pulmonary -- Anatomy -- Function -- Pulmonary Blood Flow -- Innervation -- Ventilation -- Shunts and Dead Space (Figure 2.23) -- Oxygen-Hemoglobin Dissociation Curve (Figure 2.24) -- Blood Oxygen Calculations (Figure 2.25) -- Acid-Base Balance (Figure 2.26) -- Endocrine/Exocrine -- 2.13 Renal -- Anatomy -- Function -- Renal Blood Flow -- Innervation -- Renal Volume Management (Figures 2.27 &amp -- 2.28) -- Urine Concentration (Figure 2.29) -- Acid-Base Balance -- Endocrine/Exocrine -- 2.14 Hepatic and Biliary -- Anatomy -- Function -- Hepatic Blood Flow (Figure 2.30) -- Innervation [6] -- Endocrine/Exocrine -- 2.15 Gastrointestinal -- Anatomy -- Function -- Blood Flow -- Innervation -- Endocrine -- Exocrine -- 2.16 Pancreas -- Anatomy -- Function -- Blood Supply -- Innervation.
• Endocrine/Exocrine (Figure 2.31) -- 2.17 Thyroid -- Anatomy -- Function -- Blood Supply -- Innervation -- Endocrine/Exocrine -- 2.18 Parathyroid -- Anatomy -- Function -- Blood Supply -- Innervation -- Endocrine/Exocrine (Figure 2.33) -- 2.19 Adrenal Gland -- Anatomy -- Function -- Blood Supply -- Innervation -- Endocrine/Exocrine -- 2.20 Vascular -- Anatomy (Figure 2.35) -- Function -- Innervation -- Blood Supply -- Endocrine/Exocrine -- Blood Pressure Regulation -- 2.21 Hematology -- Anatomy (Figure 2.36) -- Function -- Blood Supply -- Innervation -- Endocrine/Exocrine -- Platelet Plug and Coagulation Cascade -- Endogenous Anticoagulants -- References -- Section 3 Preoperative Assessment -- 3.1 Psychology -- Dental Fear and Anxiety -- Nonpharmacologic Behavior Management [3] -- 3.2 Sedation Levels -- Minimal Sedation -- Moderate Sedation -- Deep Sedation -- General Anesthesia -- 3.3 ASA Physical Status Classification -- ASA I -- ASA III -- ASA V -- ASA II -- ASA IV -- ASA VI -- NPO -- NPO Guidelines [4] -- Aspiration -- 3.4 Preoperative Cardiac Testing -- Procedure -- Metabolic Equivalent of Tasks (METs) -- 3.5 Preoperative Pulmonary Testing -- Chest Radiography -- Pulmonary Function Testing -- Flow-Volume Loops (Figure 3.10) -- Diffusing Lung Capacity -- 3.6 Preoperative Labs -- Blood Glucose -- Hemoglobin A1c (HbA1c) -- Basic Metabolic Panel (BMP) (Figure 3.11) -- Arterial Blood Gas -- Complete Blood Count (Figure 3.12) -- Coagulation Study (Figure 3.13) -- Liver Function Tests -- Thyroid Testing -- Pregnancy Testing -- Type and Screen -- Type and Cross -- 3.7 Airway Evaluation -- Previous Airway/Intubations History -- Presence/Suspicion of Obstructive Sleep Apnea (OSA) (Figure 3.15) -- Clinical Airway Evaluation -- Nasal Intubation Specifics -- Predictors of Difficult Airway -- References -- Section 4 Outpatient Medications.
• 4.1 Antibiotic Prophylaxis (Figures 4.1-4.6) -- Infective Endocarditis -- 4.2 Smoking -- Effects of Smoking -- Smoking Cessation [6] -- 4.3 Substance Use Disorder Treatment -- Varenicline -- Acamprosate -- Disulfiram -- Naltrexone -- Methadone -- Buprenorphine [18] -- 4.4 Antiplatelets -- Cyclooxygenase (COX) Inhibitors (NSAIDs) -- Thienopyridines -- 4.5 Anticoagulants (Figure 4.9) -- Direct Thrombin Inhibitors -- Heparin -- Warfarin -- Direct Factor Xa Inhibitors -- 4.6 Antihypertensives -- Angiotensin-Converting Enzyme Inhibitors -- Angiotensin Receptor Blockers -- Calcium Channel Blockers (Dihydropyridines) -- Nitrates -- 4.7 Diuretics -- Thiazides -- Loop Diuretics -- Potassium Sparing Diuretics -- 4.8 Antidysrhythmics -- -Blockers (Figures 4.12 &amp -- 4.13) -- Digoxin -- Calcium Channel Blockers (Non-dihydropyridines) -- 4.9 Pulmonary -- β2 Receptor Agonists -- Corticosteroids -- Anticholinergics -- Methylxanthines -- Histamine-1 Receptor Antagonists -- Leukotriene Receptor Antagonists -- 5-Lipoxygenase Inhibitors -- 4.10 Non-Insulin Hypoglycemics -- Biguanides -- Sulfonylureas -- Meglitinides -- Thiazolidinediones (TZDs) -- Sodium Glucose Cotransporter-2 Inhibitors (SGLT2) -- α-Glucosidase Inhibitors -- Dipeptidyl Peptidase-4 Inhibitors (DPP-4) -- Glucagon-Like Peptide 1 Receptor Agonists (GLP-1) -- 4.11 Insulin -- Rapid-Acting Insulin -- Regular-Acting Insulin -- Intermediate-Acting Insulin -- Long-Acting Insulin -- Insulin Pumps -- 4.12 Antidepressants -- Tricyclics (TCAs) -- Monoamine Oxidase Inhibitors (MAOIs) -- Atypical Antidepressants -- Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) -- Selective Serotonin Reuptake Inhibitors (SSRIs) -- 4.13 Psychiatric -- Antipsychotics -- α2 Adrenergic Agonists -- Lithium -- Amphetamines -- Sleep Aids -- 4.14 Neurologic -- Antiepileptics [51] -- Dopaminergics -- Cholinesterase Inhibitors.
• 4.15 Gastrointestinal -- H2 Receptor Antagonists -- Proton Pump Inhibitors (PPI) -- Antacids -- 4.16 Glucocorticosteroids -- Glucocorticosteroids -- Steroid Equivalency Chart -- 4.17 Other Medications -- Statins -- Thyroid -- Antiretrovirals -- Ophthalmic -- Herbal Medications -- α1 Adrenergic Antagonists -- References -- Section 5 The Perioperative Pharmacology -- 5.1 Inhalational Pharmacokinetics and Pharmacodynamics -- Mechanism of Action -- Minimum Alveolar Concentration (MAC) -- Minimum Alveolar Concentration (Definitions) -- Factors Affecting MAC (Figure 5.2) -- Factors Affecting Inhalational Onset -- Distribution -- Metabolism -- Elimination -- 5.2 Inhalational Agents -- Nitrous Oxide -- Isoflurane -- Desflurane -- Sevoflurane -- 5.3 Intravenous Pharmacokinetics and Pharmacodynamics -- Factors Affecting Onset -- Distribution -- Hepatic Metabolism -- Hepatic Clearance -- Renal Clearance (Figure 5.11) -- 5.4 Intravenous Induction Agents -- Propofol -- Ketamine -- Etomidate -- Methohexital -- 5.5 Benzodiazepines -- Diazepam -- Midazolam -- Remimazolam -- Flumazenil -- 5.6 Opioids -- Opioid Receptor -- Equianalgesic -- Morphine -- Fentanyl -- Hydromorphone -- Remifentanil -- Naloxone -- Other Opioids -- 5.7 Non-opioid IV Analgesics -- Ketamine -- Acetaminophen -- Ketorolac -- Dexmedetomidine -- 5.8 Neuromuscular Monitoring -- Clinical Evaluation -- Peripheral Nerve Stimulator -- Train of Four -- Nerves -- Factors Affecting Neuromuscular Blockade (Figure 5.15) -- Quantitative Neuromuscular Monitoring [60] -- 5.9 Neuromuscular Blocking Agents -- Succinylcholine -- Rocuronium -- Vecuronium -- Cisatracurium -- 5.10 Neuromuscular Reversal Agents -- Sugammadex -- Neostigmine -- Atropine -- Glycopyrrolate -- 5.11 Hypertensive Agents -- Phenylephrine -- Norepinephrine -- Epinephrine -- Ephedrine -- Vasopressin -- 5.12 Antihypertensive Agents.
• Clevidipine.
• Description based on publisher supplied metadata and other sources.